Rothschild Investment »

Aclaris Therapeutics shares owned by Rothschild Investment

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Rothschild Investment from 13F filings

Historical chart of Rothschild Investment investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Rothschild Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Rothschild Investment

Quarter filed Position value Share count Share price at filing
2025-12-31 $24 8 3.00

More positions owned by Rothschild Investment

Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Jpmorgan Chase & Co Stock (JPM)
Microsoft Corp Stock (MSFT)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Blackstone Stock (BX)
Invesco Rafi Us 1000 Etf Etf (PRF)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Amazon Stock (AMZN)
Abbvie Stock (ABBV)
Capital Group Dividend Growers Etf Etf (CGDG)
Johnson & Johnson Stock (JNJ)
Meta Platforms Inc Cl A Stock (META)
Chevron Corporation Stock (CVX)

View all positions for Rothschild Investment

Top funds holding Aclaris Therapeutics

BML Capital Management
Vivo Capital
BlackRock
Vanguard Group
Adage Capital Partners GP
Rock Springs Capital Management
Decheng Capital
Geode Capital Management
D. E. Shaw & Co
Acadian Asset Management
Palo Alto Investors
Millennium Management
State Street Corporation
Connor, Clark & Lunn Investment Management
Citadel Advisors

View all funds holding Aclaris Therapeutics